Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta‐analysis
Abstract Background Factors that are prognostic of early discontinuation of adjuvant chemotherapy among stage III colon cancer patients have yet to be described. To address this gap, a survey of medical oncologists and a systematic review and meta‐analysis were conducted. Methods A survey was distri...
Main Authors: | Devon J. Boyne, Dylan E. O'Sullivan, Emily V. Heer, Robert J. Hilsden, Tolulope T. Sajobi, Winson Y. Cheung, Darren R. Brenner, Christine M. Friedenreich |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2843 |
Similar Items
-
Adherence and Discontinuation of Optimal Heart Failure Therapies According to Age: A Danish Nationwide Study
by: Caroline H. Garred, et al.
Published: (2022-10-01) -
Connection between self-stigma, adherence to treatment, and discontinuation of medication
by: Kamaradova D, et al.
Published: (2016-07-01) -
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
by: Nethanel Asher, et al.
Published: (2021-06-01) -
Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
by: Christopher LaFratte, et al.
Published: (2023-09-01) -
Results on Discontinuity at Fixed Point for a New Class of $F$-Contractive Mappings
by: Pradip Debnath
Published: (2023-09-01)